Michael Wiederhorn

Stock Analyst at Oppenheimer

(3.70)
# 756
Out of 5,152 analysts
144
Total ratings
56.74%
Success rate
4.54%
Average return

Stocks Rated by Michael Wiederhorn

PACS Group
Mar 4, 2026
Maintains: Outperform
Price Target: $40$42
Current: $34.69
Upside: +21.07%
Teladoc Health
Mar 3, 2026
Maintains: Outperform
Price Target: $12$7
Current: $5.05
Upside: +38.61%
Evolent Health
Mar 2, 2026
Maintains: Outperform
Price Target: $12$6
Current: $3.17
Upside: +89.27%
Chemed
Feb 27, 2026
Maintains: Outperform
Price Target: $580$500
Current: $404.63
Upside: +23.57%
UnitedHealth Group
Jan 28, 2026
Maintains: Outperform
Price Target: $415$385
Current: $285.01
Upside: +35.08%
HCA Healthcare
Jan 28, 2026
Maintains: Outperform
Price Target: $500$540
Current: $532.17
Upside: +1.47%
Enhabit
Jan 22, 2026
Upgrades: Outperform
Price Target: $14
Current: $13.62
Upside: +2.83%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $33.14
Upside: -9.47%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51$43
Current: $43.30
Upside: -0.69%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300$310
Current: $180.18
Upside: +72.05%
Maintains: Outperform
Price Target: $400$375
Current: $270.96
Upside: +38.40%
Maintains: Outperform
Price Target: $34$37
Current: $33.09
Upside: +11.82%
Maintains: Outperform
Price Target: $165$168
Current: $205.51
Upside: -18.25%
Maintains: Outperform
Price Target: $140$145
Current: $101.87
Upside: +42.34%
Maintains: Outperform
Price Target: $4.5$5
Current: $3.33
Upside: +50.38%